Neuphoria Therapeutics Inc. Interest Receivable, Current
Neuphoria Therapeutics Inc. (NEUP) had Interest Receivable, Current of $0 as of 2026-06-30, per its 10-K filed 2026-09-18.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2026-09-18
- 2026-06-30: Interest Receivable, Current $0.00.
- 2026-03-31: Interest Receivable, Current $2.62K.
- 2025-12-31: Interest Receivable, Current $2.56K.
- 2025-09-30: Interest Receivable, Current $1.76K.
| Period end | Interest Receivable, Current |
|---|---|
| 2026-06-30 | $0.00 10-K · filed 2026-09-18 |
| 2026-03-31 | $2.62K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.56K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $1.76K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $237.00 10-K · filed 2026-09-18 |
| 2025-03-31 | $2.91K 10-Q · filed 2025-05-20 |
| 2024-12-31 | $2.02K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $1.28K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $286.00 10-K · filed 2025-09-29 |
| 2023-06-30 | $257.00 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |